Table of Contents Author Guidelines Submit a Manuscript
Journal of Lipids
Volume 2011 (2011), Article ID 167958, 13 pages
http://dx.doi.org/10.1155/2011/167958
Research Article

Protective Effects of Simvastatin, a Lipid Lowering Agent, against Oxidative Damage in Experimental Diabetic Rats

1Department of Chemistry for Health Sciences, Deanery of Academic Services, Health Sciences Track, Taibah University, Al-Madinah, Saudi Arabia
2Biochemistry Department, Faculty of Pharmacy, Al-Azhar University, Nasr City, Cairo, Egypt
3Department of Clinical Pharmacy, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia
4Department of Physiology, College of Medicine, Taibah University, Al-Madinah, Saudi Arabia
5Biochemistry Department, Applied Science College, Taibah University, Al-Madinah, Saudi Arabia
6Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia

Received 5 May 2011; Revised 16 July 2011; Accepted 12 September 2011

Academic Editor: Robert Salomon

Copyright © 2011 Ahmed M. Mohamadin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organization, “Prevalence of diabetes worldwide,” http://www.who.int/mediacentre/factsheets/fs312/en/index.html.
  2. J. C. N. Chan, V. Malik, W. Jia et al., “Diabetes in Asia: epidemiology, risk factors, and pathophysiology,” Journal of the American Medical Association, vol. 301, no. 20, pp. 2129–2140, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. A. C. Maritim, R. A. Sanders, and J. B. Watkins, “Diabetes, oxidative stress, and antioxidants: a review,” Journal of Biochemical and Molecular Toxicology, vol. 17, no. 1, pp. 24–38, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. A. Likidlilid, N. Patchanans, T. Peerapatdit, and C. Sriratanasathavorn, “Lipid peroxidation and antioxidant enzyme activities in erythrocytes of type 2 diabetic patients,” Journal of the Medical Association of Thailand, vol. 93, no. 6, pp. 682–693, 2010. View at Google Scholar · View at Scopus
  5. C. D. Venturini, S. Merlo, A. A. Souto, M. C. Fernandes, R. Gomez, and C. R. Rhoden, “Resveratrol and red wine function as antioxidants in the nervous system without cellular proliferative effects during experimental diabetes,” Oxidative Medicine and Cellular Longevity, vol. 3, no. 6, pp. 434–441, 2010. View at Publisher · View at Google Scholar
  6. J. D. Acharya and S. S. Ghaskadbi, “Islets and their antioxidant defense,” Islets, vol. 2, no. 4, pp. 225–235, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. T. Szkudelski, “The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas,” Physiological Research, vol. 50, no. 6, pp. 537–546, 2001. View at Google Scholar · View at Scopus
  8. N. H. Al-Rawi, “Oxidative stress, antioxidant status and lipid profile in the saliva of type 2 diabetics,” Diabetes and Vascular Disease Research, vol. 8, no. 1, pp. 22–28, 2011. View at Publisher · View at Google Scholar · View at PubMed
  9. U. N. Tripathi and D. Chandra, “Anti-hyperglycemic and anti-oxidative effect of aqueous extract of momordica charantia pulp and Trigonella foenum graecum seed in alloxan-induced diabetic rats,” Indian Journal of Biochemistry and Biophysics, vol. 47, no. 4, pp. 227–233, 2010. View at Google Scholar · View at Scopus
  10. J. Fernández-Alvarez, A. Barberà, B. Nadal et al., “Stable and functional regeneration of pancreatic beta-cell population in nSTZ-rats treated with tungstate,” Diabetologia, vol. 47, no. 3, pp. 470–477, 2004. View at Publisher · View at Google Scholar · View at PubMed
  11. D. J. Maron, S. Fazio, and M. F. Linton, “Current perspectives on statins,” Circulation, vol. 101, no. 2, pp. 207–213, 2000. View at Google Scholar · View at Scopus
  12. S. K. Ganesh, C. M. Nass, and R. S. Blumenthal, “Anti-atherosclerotic effects of statins: lessons from prevention trials,” Journal of Cardiovascular Risk, vol. 10, no. 3, pp. 155–159, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. A. S. Wierzbicki, R. Poston, and A. Ferro, “The lipid and non-lipid effects of statins,” Pharmacology and Therapeutics, vol. 99, no. 1, pp. 95–112, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. J. K. Liao and U. Laufs, “Pleiotropic effects of statins,” Annual Review of Pharmacology and Toxicology, vol. 45, pp. 89–118, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. I. Araújo-Filho, D. T. Jácome, A. C. M. Rêgo, I. M. Azevedo, E. S. T. Egito, and A. C. Medeiros, “Effect of the simvastatin in abdominal sepsis of diabetic rats,” Revista do Colegio Brasileiro de Cirurgioes, vol. 37, no. 1, pp. 39–44, 2010. View at Google Scholar
  16. T. Laing, R. Hanson, F. Chan, and D. Bouchier-Hayes, “Effect of pravastatin on experimental diabetic wound healing,” The Journal of Surgical Research, vol. 161, no. 2, pp. 336–340, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. M. S. Kostapanos, E. N. Liberopoulos, and M. S. Elisaf, “Statin pleiotropy against renal injury,” Journal of the CardioMetabolic Syndrome, vol. 4, no. 1, pp. E4–E9, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. J.-C. Ansquer, D. Crimet, and C. Foucher, “Fibrates and statins in the treatment of diabetic retinopathy,” Current Pharmaceutical Biotechnology, vol. 12, no. 3, pp. 396–405, 2011. View at Publisher · View at Google Scholar
  19. X. M. Yao, S. D. Ye, Z. Zai et al., “Simvastatin protects diabetic rats against kidney injury through the suppression of renal matrix metalloproteinase-9 expression,” Journal of Endocrinological Investigation, vol. 33, no. 5, pp. 292–296, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. M. Kuželová, A. Adameová, Z. Sumbalová et al., “The effect of simvastatin on coenzyme Q and antioxidant/oxidant balance in diabetic-hypercholesterolaemic rats,” General Physiology and Biophysics, vol. 27, no. 4, pp. 291–298, 2008. View at Google Scholar
  21. A. Cumaoǧlu, G. Ozansoy, A. M. Irat, A. Aricioǧlu, C. Karasu, and N. Ari, “Effect of long term, non cholesterol lowering dose of fluvastatin treatment on oxidative stress in brain and peripheral tissues of streptozotocin-diabetic rats,” European Journal of Pharmacology, vol. 654, no. 1, pp. 80–85, 2011. View at Publisher · View at Google Scholar · View at PubMed
  22. L. L. Stoll, M. L. McCormick, G. M. Denning, and N. L. Weintraub, “Antioxidant effects of statins,” Drugs of Today, vol. 40, no. 12, pp. 975–989, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Mazor, R. Shurtz-Swirski, R. Farah et al., “Primed polymorphonuclear leukocytes constitute a possible link between inflammation and oxidative stress in hyperlipidemic patients,” Atherosclerosis, vol. 197, no. 2, pp. 937–943, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. J. Edlund, A. Fasching, P. Liss, P. Hansell, and F. Palm, “The roles of NADPH-oxidase and nNOS for the increased oxidative stress and the oxygen consumption in the diabetic kidney,” Diabetes/Metabolism Research and Reviews, vol. 26, no. 5, pp. 349–356, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. O. Siddiqui, Y. Sun, J. C. Liu, and Y. W. Chien, “Facilitated transdermal transport of insulin,” Journal of Pharmaceutical Sciences, vol. 76, no. 4, pp. 341–345, 1987. View at Google Scholar
  26. A. D. Mooradian, M. J. Haas, O. Batejko, M. Hovsepyan, and S. S. Feman, “Statins ameliorate endothelial barrier permeability changes in the cerebral tissue of streptozotocin-induced diabetic rats,” Diabetes, vol. 54, no. 10, pp. 2977–2982, 2005. View at Publisher · View at Google Scholar
  27. O. H. Lowry, N. J. Rosenbrough, A. L. Farr, and R. Randall, “Protein determination using Folin-Ciocalteu Reagent,” Journal of Biological Chemistry, vol. 193, pp. 265–278, 1951. View at Google Scholar
  28. H. Mitsuda, K. Yuasumoto, and K. Iwami, “Antioxidation action of indole compounds during the autoxidation of linoleic acid,” Eiyo to Shokuryo, vol. 19, pp. 210–214, 1996. View at Google Scholar
  29. K. Shimada, K. Fujikawa, K. Yahara, and T. Nakamura, “Antioxidative properties of xanthan on the autoxidation of soybean oil in cyclodextrin emulsion,” Journal of Agricultural and Food Chemistry, vol. 40, no. 6, pp. 945–948, 1992. View at Google Scholar
  30. P. Trinder, “Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen,” Journal of Clinical Pathology, vol. 22, no. 2, pp. 158–161, 1969. View at Google Scholar · View at Scopus
  31. W. T. Friedewald, R. I. Levy, and D. S. Fredrickson, “Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge,” Clinical Chemistry, vol. 18, no. 6, pp. 499–502, 1972. View at Google Scholar · View at Scopus
  32. S. Reitman and S. Frankel, “A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases,” American Journal of Clinical Pathology, vol. 28, no. 1, pp. 56–63, 1957. View at Google Scholar · View at Scopus
  33. G. L. Ellman, “Tissue sulfhydryl groups,” Archives of Biochemistry and Biophysics, vol. 82, no. 1, pp. 70–77, 1959. View at Google Scholar · View at Scopus
  34. S. T. Omaye, J. David Turnbull, and H. E. Sauberlich, “Selected methods for the determination of ascorbic acid in animal cells, tissues, and fluids,” Methods in Enzymology, vol. 62, pp. 3–11, 1979. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Uchiyama and M. Mihara, “Determination of malonaldehyde precursor in tissues by thiobarbituric acid test,” Analytical Biochemistry, vol. 86, no. 1, pp. 271–278, 1978. View at Google Scholar · View at Scopus
  36. S. Marklund and G. Marklund, “Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase,” European Journal of Biochemistry, vol. 47, no. 3, pp. 469–474, 1974. View at Google Scholar · View at Scopus
  37. H. Aebi, “Catalase,” in Methods in Enzymatic Analysis, H. U. Bergmeyer, Ed., vol. 3, pp. 276–286, Academic Press, New York, NY, USA, 1983. View at Google Scholar
  38. R. A. Lawrence and R. F. Burk, “Glutathione peroxidase activity in selenium deficient rat liver,” Biochemical and Biophysical Research Communications, vol. 71, no. 4, pp. 952–958, 1976. View at Google Scholar · View at Scopus
  39. K. Hiramatsu and S. Arimori, “Increased superoxide production by mononuclear cells of patients with hypertriglyceridemia and diabetes,” Diabetes, vol. 37, no. 6, pp. 832–837, 1988. View at Google Scholar · View at Scopus
  40. S. P. Wolff, Z. Y. Jiang, and J. V. Hunt, “Protein glycation and oxidative stress in diabetes mellitus and ageing,” Free Radical Biology and Medicine, vol. 10, no. 5, pp. 339–352, 1991. View at Publisher · View at Google Scholar · View at Scopus
  41. N. Haugaard, “Cellular mechanisms of oxygen toxicity,” Physiological Reviews, vol. 48, no. 2, pp. 311–373, 1968. View at Google Scholar · View at Scopus
  42. R. A. Sanders, F. M. Rauscher, and J. B. Watkins, “Effects of Quercetin on antioxidant defense in streptozotocin-induced diabetic rats,” Journal of Biochemical and Molecular Toxicology, vol. 15, no. 3, pp. 143–149, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. C. Yabe-Nishimura, “Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications,” Pharmacological Reviews, vol. 50, no. 1, pp. 21–33, 1998. View at Google Scholar · View at Scopus
  44. M. Inouye, H. Hashimoto, T. Mio, and K. Sumino, “Levels of lipid peroxidation product and glycated hemoglobin A1c in the erythrocytes of diabetic patients,” Clinica Chimica Acta, vol. 276, no. 2, pp. 163–172, 1998. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Inouye, T. Mio, and K. Sumino, “Glycated hemoglobin and lipid peroxidation in erythrocytes of diabetic patients,” Metabolism, vol. 48, no. 2, pp. 205–209, 1999. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Elgawish, M. Glomb, M. Friedlander, and V. M. Monnier, “Involvement of hydrogen peroxide in collagen cross-linking by high glucose in vitro and in vivo,” Journal of Biological Chemistry, vol. 271, no. 22, pp. 12964–12971, 1996. View at Publisher · View at Google Scholar · View at Scopus
  47. S. I. McFarlane, R. Muniyappa, R. Francisco, and J. R. Sowers, “Clinical review 145: pleiotropic effects of statins: lipid reduction and beyond,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 4, pp. 1451–1458, 2002. View at Publisher · View at Google Scholar · View at Scopus
  48. K. K. Ray and C. P. Cannon, “The potential relevance of the multiple lipid-independent (pleiotropic) effects of statins in the management of acute coronary syndromes,” Journal of the American College of Cardiology, vol. 46, no. 8, pp. 1425–1433, 2005. View at Publisher · View at Google Scholar · View at PubMed
  49. T. Taldone, S. W. Zito, and T. T. Talele, “Inhibition of dipeptidyl peptidase-IV (DPP-IV) by atorvastatin,” Bioorganic and Medicinal Chemistry Letters, vol. 18, no. 2, pp. 479–484, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  50. Y. Ohara, T. E. Peterson, and D. G. Harrison, “Hypercholesterolemia increases endothelial superoxide anion production,” Journal of Clinical Investigation, vol. 91, no. 6, pp. 2546–2551, 1993. View at Google Scholar · View at Scopus
  51. T. Inoguchi, P. Li, F. Umeda et al., “High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells,” Diabetes, vol. 49, no. 11, pp. 1939–1945, 2000. View at Google Scholar · View at Scopus
  52. S. Golbidi, S. A. Ebadi, and I. Laher, “Antioxidants in the treatment of diabetes,” Current Diabetes Reviews, vol. 7, no. 2, pp. 106–125, 2011. View at Publisher · View at Google Scholar
  53. N. Matikainen, J. Kahri, and M. R. Taskinen, “Reviewing statin therapy in diabetes—towards the best practise,” Primary Care Diabetes, vol. 4, no. 1, pp. 9–15, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  54. P. E.T. Arkkila, P. J. Koskinen, I. M. Kantola, T. Rönnemaa, E. Seppänen, and J. S. Viikari, “Diabetic complications are associated with liver enzyme activities in people with type 1 diabetes,” Diabetes Research and Clinical Practice, vol. 52, no. 2, pp. 113–118, 2001. View at Publisher · View at Google Scholar
  55. A. Imaeda, T. Kaneko, T. Aoki et al., “Antioxidative effects of fluvastatin and its metabolites against DNA damage in streptozotocin-treated mice,” Food and Chemical Toxicology, vol. 40, no. 10, pp. 1415–1422, 2002. View at Publisher · View at Google Scholar · View at Scopus
  56. S. P. Panda, P. K. Haldar, S. Bera, S. Adhikary, and C. C. Kandar, “Antidiabetic and antioxidant activity of Swietenia mahagoni in streptozotocin-induced diabetic rats,” Pharmaceutical Biology, vol. 48, no. 9, pp. 974–979, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  57. B. P. Yu, “Cellular defenses against damage from reactive oxygen species,” Physiological Reviews, vol. 74, no. 1, pp. 139–162, 1994. View at Google Scholar · View at Scopus
  58. J. V. Hunt, “Ascorbic acid and diabetes mellitus,” Sub-Cellular Biochemistry, vol. 25, pp. 369–405, 1996. View at Google Scholar · View at Scopus
  59. W. G. Levine, “Interaction of ascorbic acid and α-tocopherol,” Annals of Nutrition Academy of Science, vol. 498, pp. 186–199, 1990. View at Google Scholar
  60. J. M. May and Z.-C. Qu, “Ascorbic acid prevents oxidant-induced increases in endothelial permeability,” BioFactors, vol. 37, no. 1, pp. 46–50, 2011. View at Publisher · View at Google Scholar
  61. M. Schachter, “Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update,” Fundamental and Clinical Pharmacology, vol. 19, no. 1, pp. 117–125, 2005. View at Publisher · View at Google Scholar · View at PubMed
  62. R. W. Mahley and T. P. Bersot, “Drug therapy for hypercholesterolemia and dyslipidemia,” in The Pharmacological Basis of Therapeutics, A. G. Gilman, L. S. Goodman, T. W. Rall, and F. Murad, Eds., pp. 933–966, McGraw Hill Medical Publishing Div., New Delhi, India, 11th edition, 2006. View at Google Scholar
  63. D. Pitocco, F. Zaccardi, E. Di Stasio et al., “Oxidative stress, nitric oxide, and diabetes,” The Review of Diabetic Studies, vol. 7, no. 1, pp. 15–25, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  64. M. Sefi, H. Fetoui, N. Lachkar et al., “Centaurium erythrea (Gentianaceae) leaf extract alleviates streptozotocin-induced oxidative stress and β-cell damage in rat pancreas,” Journal of Ethnopharmacology, vol. 135, no. 2, pp. 243–250, 2011. View at Publisher · View at Google Scholar · View at PubMed
  65. P. Santhakumari, A. Prakasam, and K. V. Pugalendi, “Modulation of oxidative stress parameters by treatment with Piper betle leaf in streptozotocin induced diabetic rats,” Indian Journal of Pharmacology, vol. 35, no. 6, pp. 373–378, 2003. View at Google Scholar · View at Scopus
  66. M. A. Satheesh and L. Pari, “Antioxidant effect of Boerhavia diffusa L. in tissues of alloxan induced diabetic rats,” Indian Journal of Experimental Biology, vol. 42, no. 10, pp. 989–992, 2004. View at Google Scholar · View at Scopus
  67. M. Aragno, E. Brignardello, E. Tamagno, V. Gatto, O. Danni, and G. Boccuzzi, “Dehydroepiandrosterone administration prevents the oxidative damage induced by acute hyperglycemia in rats,” Journal of Endocrinology, vol. 155, no. 2, pp. 233–240, 1997. View at Publisher · View at Google Scholar
  68. E. Pigeolet, P. Corbisier, A. Houbion et al., “GLutathione peroxidase, superoxide dismutase, and catalase inactivation by peroxides and oxygen derived free radicals,” Mechanisms of Ageing and Development, vol. 51, no. 3, pp. 283–297, 1990. View at Publisher · View at Google Scholar · View at Scopus
  69. R. K. Sindhu, J. R. Koo, C. K. Roberts, and N. D. Vaziri, “Dysregulation of hepatic superoxide dismutase, catalase and glutathione peroxidase in diabetes: response to insulin and antioxidant therapies,” Clinical and Experimental Hypertension, vol. 26, no. 1, pp. 43–53, 2004. View at Publisher · View at Google Scholar · View at Scopus